DJIA 16,563.30 -317.06 -1.88%
NASDAQ 4,369.77 -93.13 -2.09%
S&P 500 1,930.67 -39.40 -2.00%
market minute promo

250.83 -6.42 (-2.50%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

IBB $250.83 -2.50%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $254.78
Previous Close $257.25
Daily Range $250.01 - $255.46
52-Week Range $187.05 - $275.40
Market Cap $5.2B
P/E Ratio -1,118.48
Dividend (Yield) $1.57 (0.2%)
Ex-Dividend Date
Dividend Pay Date
Volume 1,710,109
Average Daily Volume 1,333,081
Current FY EPS $0.00




Financial Services

iShares NASDAQ Biotechnology Index (ETF) (IBB) Description

The investment seeks investment results that correspond generally to the price and yield performance before fees and expenses of the NASDAQ Biotechnology Index (the underlying index). Website:

News & Commentary

Is This the Most Undervalued Biotech of 2013?

Biotechs roared in 2013. Questcor was no exception, but it still just might be the most undervalued biotech of the year.

Biotech Earnings Put These ETFs in Focus - ETF News And Commentary

Scientists Just Reversed Paralysis

Does This “Nuclear” Stock Pass Our Stress Test?

Conatus Pharmaceuticals: Large Upside With Attractive Risk And Income Profiles

The Fed Calls Out Biotech... Is It Time To Sell?

Health Care Select Is Among This Year???s Hottest Health Care ETFs

This Year's Hottest Healthcare ETFs

Today's Market: Biotech Names Rallying Today

S&P 500 Revenue Trends Are Improving in Q2

Companies are reporting very solid revenues this earnings season.

The Fed's Valuation Concerns Put These Growth ETFs in Focus - ETF News And Commentary

See More IBB News...

IBB's Top Competitors

IBB $250.83 (-2.50%)
Current stock: IBB
ZTR $14.08 (-1.54%)
Current stock: ZTR
VTA $12.85 (-0.39%)
Current stock: VTA
ERC $14.53 (-1.56%)
Current stock: ERC